Stockreport

Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference

Bolt Biotherapeutics, Inc.  (BOLT) 
PDF REDWOOD CITY, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapie [Read more]